Capital Point Ltd.

www.capitalpoint.co.il (under construction)

Investment Company
Public Company

(TASE: CPTP)

Tech Verticals Preferences

Energy Tech, Environment, Hardware, Industrial Technologies, Materials, Medical Devices, MedTech

General Data

Established	2000
Current Active Portfolio Companies:	10
Reg. Number:	abCDe

DESCRIPTION

Capital Point is an investment company traded at the Tel-Aviv Stock Exchange (CPTP). Until 2012 Capital Point focused on early stage science-based companies and managed two technology incubators. It has accumulated vast experience in the process of screening, evaluation and mentoring of early stage companies.

In 2012 Capital Point decided to diversify its portfolio and to be more opportunity oriented. The Company's objective is add significant value to the portfolio for the benefit of shareholders in its portfolio companies as well as in Capital itself in the short, medium and long range.

REMARKS

Date	Remark
01/10/2021	Musach Ravia 2009 Ltd. purchased shares of Capital Point through TASE and currently holds 8.5% of the company.
	Following its investment in Capital Point, CFH maintained a strategic cooperation agreement with the company, according to which CFH invested in companies incubated in the Ofakim and Meytag incubators.

CONTACT INFO

Expand / Collapse All

Main Address: Tel Aviv, Israel

Address	132 Menachem Begin Rd., Azrieli Center, Round Tower, 22th Floor
City	Tel Aviv
Country	Israel
Zip	6701101

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Dr. Yehoshua Gleitman	Chairman	Ascend Technology Ventures (General Partner)
Prof. Yossi Tamar	CEO
Mr. Shay Itzack-Lior	Co-CEO	Capital Point (Co-CEO)
Mr. Avi Katzav	VP, Finance	Dekolink (CFO)
Prof. Yehuda Kahane	Director
Mr. David Meir Dolev-Lipitz	Founder

Public Offerings

Deal Date	Type of Offering	Exchange	Amount Raise	Valuation	Remarks
Oct. 19, 2010	Second Public Offering	TASE	abCDe	abCDe	Could raise an additional $3m through options.
May. 30, 2006	IPO	TASE	abCDe	abCDe

	FINANCIAL ROUNDS

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Investment in Fund

Jul. 05, 2021

abCDe

CBI received 9.7% of Capital Point shares (plus cash) in exchange for 17% of eXIthera

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Investment Company	abCDe	CBI received 9.7% of Capital Point shares (plus cash) in exchange for 17% of eXIthera

Buyout

Sep. 11, 2011

abCDe

The buyout was from Maayan Ventures.

* New investor

Investor	Type	Amount	Remarks
abC Defghij	N/A	abCDe	Boughtout Maayan Ventures.
abC Defghij	N/A	abCDe	Boughtout Maayan Ventures.

Other

Jul. 11, 2007

abCDe

Other

Jan. 01, 2003

abCDe

Other

Jan. 01, 2000

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Venture Capital Fund	abCDe
abC Defghij	Fund of Funds	abCDe	(6%)
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Private Investor	abCDe	(4.8%). CEO, Gilat Satellite Networks Ltd.
abC Defghij	Private Investor	abCDe	11/2015: Holds 4.5% of the company.
abC Defghij	Private Investor	abCDe	(5.41%)
abC Defghij	Private Investor	abCDe	(5.5%)
abC Defghij	Other	abCDe	(5.5%)
abC Defghij	Private Investor	abCDe	04/2015: Holds 23.4% of the company.
abC Defghij	Private Investor	abCDe	04/2015: Holds 21.3% of the company.
abC Defghij	Investment Bank	abCDe
abC Defghij	Private Investor	abCDe	08:2014: Holds 1.53% of the company.

Other

abCDe

Investment Data

Preferences

Type of Financing	Equity
Stage Preferences	R&D,Seed
Phase Preferences	Clinical Trials,Discovery,Phase I,Pre Clinical

SECTOR SEGMENTATION (By Number Of Companies)

Medical Devices

37%

Hardware & Industrial

25%

Biomed

25%

Enterprise Software & Infrastructure

13%

	PORTFOLIO COMPANIES

Current Portfolio Companies (10)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Check-Cap

Fourth Round

19/02/2015

N/A

$12m

ConTIPI Medical

ConTIPI is a provider of nonsurgical and disposable vaginal solutions for women, intended for various pelvic floor dysfunctions. The company offers devices such as stress urinary incontinence and pelvic organ prolapse, enabling women to be safe and tension-free all day long.

Second Round

07/11/2018

N/A

$3m

Enlivex

Biomed

Fourth Round	17/09/2018	N/A	$5.3m
Second Round	18/05/2014	$0.6m	$8m

eXIthera

Biomed

Secondary Deal

05/07/2021

$5.75m

CBI sold 17% of eXIthera to Capital Point in exchange for $3.85m in cash and $1.9m in Capital Point shares (9.7%)

Fourier

HW & Indust.

Seed

01/01/2022

N/A

$1.9m

Intuition Robotics

HW & Indust.

Third Round	29/08/2023	N/A	$20m
Second Round	13/02/2020	N/A	$36m

Medasense

Seed

31/12/2008

N/A

$1m

Meytag

N/A

Buyout	31/01/2009	$0.8m	N/A	Completed control by acquiring the share (20%) of the other investors for $0.8m
Other	01/07/2003	N/A	N/A

Ofakim

N/A

Other

01/12/2002

N/A

Holds 100% of the company

Visionary.ai

Ent. SW

Seed - Extended	08/09/2022	N/A	$3m
Seed - Extended	28/02/2022	N/A	$2.5m
Seed	15/02/2021	N/A	$4.5m

Exits (13)

Company Name	Exit Type	Date Announced	Amount	Remarks
abC Defghij	IPO	19/02/2015	abCDe	In addition, $12m were raised in a simultaneous private placement of the same securities.
abC Defghij	Acquired	01/02/2013	abCDe
abC Defghij	Acquired	07/05/2023	abCDe
abC Defghij	IPO	28/06/2018	abCDe
abC Defghij	Acquired	24/01/2017	abCDe	Capital Point Ltd. (TASE:CPTP), which owns a 13.6% stake in Lithotech, reported that the acquisition is for NIS 10m in cash and a further NIS 3m in milestone performance payments.
abC Defghij	Acquired	18/10/2017	abCDe
abC Defghij	IPO	14/11/2014	abCDe
abC Defghij	Acquired	14/06/2005	abCDe	In cash.
abC Defghij	Acquired	01/10/2006	abCDe
abC Defghij	IPO	28/10/2024	abCDe
abC Defghij	Acquired	30/04/2020	abCDe	Innovate Biopharmaceuticals purchased RDD Pharma in a share swap deal and changed its name to 9 Meters Biopharma.
abC Defghij (Incubator)	Acquired	18/11/2021	abCDe	NIS 48m; Valuation NIS 196m
abC Defghij	Acquired	22/08/2025	abCDe	Following the acquisition, Xylo become a wholly-owned subsidiary of L.I.A. Pure Capital and was delisted from Nasdaq.

Historic Portfolio (45)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Advanced Interventional...

Ceased to Operate

Seed

22/07/2009

N/A

$0.1m

AGS Gal Systems

Ceased to Operate

HW & Indust.

Seed

01/07/2006

N/A

Through Meytag High-Tech Ventures Incubator

AquaSpark

Written Off

Cln.

Seed

31/12/2008

N/A

$0.1m

Arch Medical Devices

Suspendeed Operations

Seed

15/02/2011

N/A

$0.75m

BioCep

Suspendeed Operations

Biomed

Third Round	01/06/2018	N/A	N/A
Second Round	09/07/2013	$0.5m	$5.3m
Seed	01/06/2006	N/A	$1.39m

Cardio Dynamics

Ceased to Operate

Seed

01/07/2008

$0.045m

$0.09m

Chi2Gel

Ceased to Operate

Seed

13/05/2010

$0.05m

$0.1m

Coeruleus

Ceased to Operate

Biomed

First Round	01/06/2011	N/A	$0.9m
Seed	21/02/2010	$0.05m	$0.16m	Through Meytag High-Tech Ventures.

ConjuGate

Ceased to Operate

Biomed

Seed

17/01/2006

N/A

$0.15m

Holds 2.3% of the company (Outside Ofakim's holding in the company)

Deliverance

Ceased to Operate

Seed

24/03/2009

N/A

$0.15m

DermiPsor

Suspendeed Operations

Biomed

Fifth Round	07/01/2010	N/A	$0.288m	Holds 39% of the company
Third Round	11/02/2007	$0.1m	$0.6m
Second Round	01/12/2006	N/A	$0.6m
First Round	01/03/2005	N/A	$0.25m
Seed	01/06/2004	N/A	$0.34m

Ecofer

Ceased to Operate

Agri

First Round	12/02/2013	N/A	N/A
Seed	25/07/2010	N/A	$0.1m

Fasttack

Ceased to Operate

Seed

31/12/2008

N/A

$0.1m

Forconti

Ceased to Operate

First Round	01/10/2013	N/A	N/A
Seed	24/05/2011	$0.05m	$0.6m

FriCSo

Ceased to Operate

Energy

Bridge - Extended	01/01/2012	N/A	N/A
Bridge	01/01/2009	N/A	N/A
Seed	01/06/2003	N/A	$0.6m	Direct Holdings

Hi-Cell

Ceased to Operate

Energy

Seed

01/06/2006

N/A

Holds 50.5% of the company (Outside Meytag's holding in the company)

ImmunoBar

Ceased to Operate

Biomed

Seed

01/10/2004

N/A

$0.1m

Through Meytag High-Tech Ventures Incubator

Indoorgo

Ceased to Operate

Network Infra.

Seed

01/03/2012

N/A

$0.3m

InMotion

Written Off

First Round	01/06/2010	N/A	N/A
Seed	31/12/2008	N/A	$0.6m

Kadoor Microelectronics

Ceased to Operate

Semicon.

Seed

24/05/2011

N/A

$0.1m

LinkaGene

Ceased to Operate

Biomed

Seed

01/10/2000

N/A

Direct Holdings

LRS Ortho

Ceased to Operate

Bridge	26/04/2009	$0.075m	$0.3m	Holds 46% of the company
Seed	24/10/2006	N/A	$0.6m	Through Meytag High-Tech Ventures Incubator

Mellitor

Suspendeed Operations

Bridge	07/06/2010	$0.028m	$0.308m
Seed	01/05/2007	N/A	$0.1m

Mitam Biological Control

Ceased to Operate

Agri

First Round	01/04/2008	N/A	$0.3m
Seed	01/09/2004	$0.1m	$6m	Through Meytag High-Tech Ventures Incubator

NeD

Ceased to Operate

Dig. Health

Bridge	09/07/2009	N/A	$0.25m
Seed	29/11/2006	N/A	$0.09m	Through Meytag High-Tech Ventures Incubator

Nehora Photonics

Ceased to Operate

First Round	19/07/2011	N/A	$0.48m
Seed	31/12/2008	N/A	$0.1m

Newton

Suspendeed Operations

Energy

First Round	16/11/2008	N/A	$0.57m	Through Meytag High-Tech Ventures Incubator
Seed	01/06/2006	N/A	$0.1m	Through Meytag High-Tech Ventures Incubator

NovoSurge

Ceased to Operate

Seed - Extended

25/10/2010

$0.045m

$0.09m

Odem Medical

Ceased to Operate

Seed

07/11/2006

N/A

$0.58m

Through Meytag High-Tech Ventures Incubator. Holds 49.7% from the company

OraDel

Ceased to Operate

Biomed

Seed

01/01/2003

N/A

$0.08m

Through Meytag High-Tech Ventures Incubator

Orthogon

Ceased to Operate

$Orthogon had developed a unique technology which brings intelligence into an otherwise simple device – the intramedullary nail. The technology turns the nail into a dynamic device, which is controlled, non-invasively, by an external magnetic field, generated by a proprietary coil. The device is used for limb elongation, non-union fractures and as a primary fixator which will expediate the total healing time of fractures.$

First Round	01/10/2007	N/A	$0.95m	Holds 12% of the company
Seed	01/10/2003	N/A	$0.15m	Through Ofakim Hi-Tech Ventures Incubator

Pyramidion

Ceased to Operate

Second Round	12/07/2011	N/A	$1m	Holds 2.05% of the company (outside Ofakim's holding in the company)
First Round	01/10/2009	N/A	$0.205m
Seed	01/10/2004	N/A	$0.25m

Rescue Medical

Ceased to Operate

Seed

01/06/2006

N/A

$0.45m

Holds 48.8% of the company (Outside Meytag's holding in the company)

RighTune

Ceased to Operate

CO SW

First Round

01/05/2013

$0.7m

Roei

Ceased to Operate

Seed

01/06/2001

N/A

$0.5m

Holds 7.2% of the company (Outside Meytag's holding in the company)

RxDrugOn

Ceased to Operate

Dig. Health

Seed

27/04/2009

N/A

$0.1m

SaferPoint

Ceased to Operate

Ent. SW

Seed

01/02/2012

$0.1m

$0.19m

SenseGon

Ceased to Operate

CO SW

First Round	01/12/2013	N/A	$1.5m
Seed	31/03/2011	N/A	$1.8m

Silvi Software

Ceased to Operate

Ent. SW

Seed

30/11/2010

$0.04m

$0.08m

Spinal Ballon

Ceased to Operate

Seed

08/08/2010

$0.05m

$0.1m

SpiroJet

Ceased to Operate

Seed

01/08/2002

N/A

$0.3m

Through Meytag High-Tech Ventures Incubator

TCView

Ceased to Operate

HW & Indust.

Seed

22/07/2009

N/A

$0.1m

Veterix

Suspendeed Operations

Agri

Seed

01/10/2004

$0.3m

$0.4m

Through Meytag High-Tech Ventures Incubator

WiFunTV

Suspendeed Operations

Network Infra.

First Round

01/01/2013

N/A

WizBill

Ceased to Operate

Ent. SW

Seed

30/06/2009

N/A

$0.1m

Last Updated:	abCDe
IVC Number:	abCDe